Assessment of Trimetazidine Treatment in Acute Myocardial Infarction Patients Undergoing Percutaneous Coronary Intervention

Table 3

Baseline laboratory data at admission.

	TMZ group (n = 200)	Control group (n = 201)	value
CK (U/L)	214 ± 152	203 ± 117	0.446
CKMB (U/L)	28 ± 15	26 ± 13	0.238
cTNI (ng/ml)	1.9 ± 1.8	1.6 ± 1.6	0.117
ALT (U/L)	37.2- ± 23.4	36.8 ± 22.3	0.888
AST (U/L)	117.3 ± 132.9	112.4 ± 97.6	0.670
Cr (μmol/L)	81.8 ± 24.6	79.1 ± 28.9	0.316
Urea (mmol/L)	7.1 ± 1.9	6.9 ± 8.4	0.789
Glucose (mmol/L)	7.8 ± 2.9	7.6 ± 2.8	0.363

CK and CK-MB, serum creatine kinase and its isoenzyme; cTNI, cardiac troponin I; Cr, serum creatinine; ALT, serum glutamic pyruvic transaminase; AST, serum glutamic oxaloacetic transaminase.